We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Biopharma

Biopharma

Stay up to date on the topics that matter to you

Trending News

B cells.

Building Better Antibodies and Curbing Autoimmune Diseases

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

What Happens to the Human Body After 200 Vaccines?

Immune System Involvement in Dermatomyositis Revealed

Protein That Controls CAR T-Cell Longevity Identified

News

Innovent Biologics Expands its Antibody Pipeline and Manufacturing Capabilities

Company raises $25 million in a Series B financing.

Vaccine for Killer Disease One Step Closer

New 4CMenB vaccine designed to cover most strains of the disease in Europe.

A Comparative Medicine Study by Penn Vet Identifies a New Approach to Combat Viral Infections

When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack.

GE Healthcare Scientist Paired with Cardiff MP to Share Insights on Cell Therapy, Science and Policy-Making

Dr. Michelle Janas from GE Healthcare Life Sciences visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme run by the Royal Society.

Biologics and Stem Cell Research Boost the Cell Culture Market

Cell culture market expected to grow at a CAGR of 9.3% between 2011 and 2018.

Fujifilm Diosynth Biotechnologies Manufactures a New Licensed Biopharmaceutical

ThromboGenics' has received FDA approval for the launch of JETREA® in the USA.

Two Business Units with New Management

Leadership change at Bosch Packaging Technology.

immatics Appoints Peter Chambré as Chairman

Peter Chambré will replace Thomas Widmann.

immatics’ Renal Cancer Vaccine IMA901 Completes Phase 3 Patient Recruitment

Drug is granted US orphan drug designation by the FDA.

Vaccine Technology Takes Dramatic Step Forward

New and increasingly sophisticated vaccines are taking aim at a broad range of disease-causing pathogens, targeting them with greater effectiveness at lower cost and with improved measures to ensure safety.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter